Total: $118.76M

Company
(Symbol)#
(M)

Type Of Financing

Number Of Shares, Units Or Warrants

Amount Raised (M)

Investors; Placement Agents; Details (Date)@

Cell Thera-
peutics Inc.
(CTIC)

Private placement of convertible subordinated notes

N/A

$25

Cell Therapeutics raised an additional $25M aggregate principal amount of 5.7% convertible subordinated notes due 2008, bringing the total amount raised to $175M; the $25M represents an exercised overallotment option to a $150M private placement conducted in June (9/10)

Chiron
Corp.
(CHIR)

Private placement of 30-year liquid option notes

5.2S

$400

Chiron raised $400M in the placement, which was completed in June; the company did not disclose the name of the purchaser (6/7***)

Dragon
Pharma-
ceuticals
Inc.
(Canada;
OTCBB:
DRUG)

Private placement of units

3.5U

$7

Dragon placed 3.5M units at $2 per unit, raising $7M (9/18)

Medarex
Inc.
(MEDX)

Offering of convertible notes

N/A

$175

Medarex raised $175M through an offering of convertible notes in June; Goldman Sachs & Co., Credit Suisse First Boston, JP Morgan, Morgan Stanley Dean Witter, Bear, Stearns & Co. Inc. and Dain Rauscher Wessels were the underwriters (6/19***)

PPL Thera-
peutics
plc (Scotland;
LSE:PTH)

Private equity financing

N/A

£30 (US
$43.3)

PPL Therapeutics received "non-binding commitments“ from investors to a discounted rights issue at 50 pence per share; the commitments are from institutional investors that are existing shareholders; the issue is being underwritten by Deutsche Bank (9/5**)

Protalex
Inc. (OTC
BB:PRTX)

Private placement of common stock

N/A

$1.1

Protalex raised $1.1M in a private placement of common stock (9/11)

SIGA
Technol-
ogies Inc.
(SIGA)

Private placement of common stock and warrants

0.4S and W for 0.3S

$1.16

SIGA received $1.16M from a private placement of 409,636 shares of common stock and warrants to purchase 307,226 shares of common stock, to a group of investors, including members of the company's board (9/20)

Synaptic
Pharma-
ceutical
Corp.
(SNAP)
preferred stock

Private placement of convertible

5.4S

$31.6

Synaptic raised $31.6M in the second part of a convertible preferred stock offering; the first part of the offering brought in $9.4M in August (9/27)

ViroLogic
Inc.
(VLGC)

Private placement of common stock

N/A

$9.6

ViroLogic received $9.6M, the final tranche of a $16.25M private placement; the first tranche of $6.65M closed in July; UBS Warburg LLC and CIBC World Markets Corp. served as advisers (9/28)

Notes:

# Unless otherwise indicated, shares are traded on the Nasdaq exchange.

@ Dates refer to the date of the press release.

*** The Chiron and Medarex financings occurred in June. The figures are not included in the September totals, but are included in the June totals of the chart on page 12.

N/A = Not available or reported.

LSE = London Stock Exchange; OTC BB = Over the Counter Bulletin Board